204 related articles for article (PubMed ID: 30315942)
1. Manufacture of Chimeric Antigen Receptor T Cells from Mobilized Cyropreserved Peripheral Blood Stem Cell Units Depends on Monocyte Depletion.
Künkele A; Brown C; Beebe A; Mgebroff S; Johnson AJ; Taraseviciute A; Rolczynski LS; Chang CA; Finney OC; Park JR; Jensen MC
Biol Blood Marrow Transplant; 2019 Feb; 25(2):223-232. PubMed ID: 30315942
[TBL] [Abstract][Full Text] [Related]
2. Manufacturing chimeric antigen receptor T cells from cryopreserved peripheral blood cells: time for a collect-and-freeze model?
Palen K; Zurko J; Johnson BD; Hari P; Shah NN
Cytotherapy; 2021 Nov; 23(11):985-990. PubMed ID: 34538575
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte Colony Stimulating Factor-Mobilized Peripheral Blood Mononuclear Cells: An Alternative Cellular Source for Chimeric Antigen Receptor Therapy.
Ballesteros-Ribelles A; Millán-López A; Carmona-Luque M; Herrera C
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891957
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic and functional attributes of lentivirus-modified CD19-specific human CD8+ central memory T cells manufactured at clinical scale.
Wang X; Naranjo A; Brown CE; Bautista C; Wong CW; Chang WC; Aguilar B; Ostberg JR; Riddell SR; Forman SJ; Jensen MC
J Immunother; 2012; 35(9):689-701. PubMed ID: 23090078
[TBL] [Abstract][Full Text] [Related]
5. Effects of cryopreservation on chimeric antigen receptor T cell functions.
Xu H; Cao W; Huang L; Xiao M; Cao Y; Zhao L; Wang N; Zhou J
Cryobiology; 2018 Aug; 83():40-47. PubMed ID: 29908946
[TBL] [Abstract][Full Text] [Related]
6. NKT Cells Coexpressing a GD2-Specific Chimeric Antigen Receptor and IL15 Show Enhanced
Xu X; Huang W; Heczey A; Liu D; Guo L; Wood M; Jin J; Courtney AN; Liu B; Di Pierro EJ; Hicks J; Barragan GA; Ngai H; Chen Y; Savoldo B; Dotti G; Metelitsa LS
Clin Cancer Res; 2019 Dec; 25(23):7126-7138. PubMed ID: 31484667
[TBL] [Abstract][Full Text] [Related]
7. [Relevant low toxicities with rhG-CSF mobilized and cryopreserved autologous peripheral blood stem cell return infusions in children].
Wang JW; Tang SQ; Lü SG; Ran CR; Yang G; Liu Y; Gao XN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):404-7. PubMed ID: 17493357
[TBL] [Abstract][Full Text] [Related]
8. Eradication of Neuroblastoma by T Cells Redirected with an Optimized GD2-Specific Chimeric Antigen Receptor and Interleukin-15.
Chen Y; Sun C; Landoni E; Metelitsa L; Dotti G; Savoldo B
Clin Cancer Res; 2019 May; 25(9):2915-2924. PubMed ID: 30617136
[TBL] [Abstract][Full Text] [Related]
9. A large-scale method for T cell depletion: towards graft engineering of mobilized peripheral blood stem cells.
Gordon PR; Leimig T; Mueller I; Babarin-Dorner A; Holladay MA; Houston J; Kerst G; Geiger T; Handgretinger R
Bone Marrow Transplant; 2002 Jul; 30(2):69-74. PubMed ID: 12132044
[TBL] [Abstract][Full Text] [Related]
10. Effect of Cryopreservation on Autologous Chimeric Antigen Receptor T Cell Characteristics.
Panch SR; Srivastava SK; Elavia N; McManus A; Liu S; Jin P; Highfill SL; Li X; Dagur P; Kochenderfer JN; Fry TJ; Mackall CL; Lee D; Shah NN; Stroncek DF
Mol Ther; 2019 Jul; 27(7):1275-1285. PubMed ID: 31178392
[TBL] [Abstract][Full Text] [Related]
11. Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia.
Rozenbaum M; Meir A; Aharony Y; Itzhaki O; Schachter J; Bank I; Jacoby E; Besser MJ
Front Immunol; 2020; 11():1347. PubMed ID: 32714329
[TBL] [Abstract][Full Text] [Related]
12. Autologous cryopreserved leukapheresis cellular material for chimeric antigen receptor-T cell manufacture.
Tyagarajan S; Schmitt D; Acker C; Rutjens E
Cytotherapy; 2019 Dec; 21(12):1198-1205. PubMed ID: 31837735
[TBL] [Abstract][Full Text] [Related]
13. In vitro generation of dendritic cells derived from cryopreserved CD34+ cells mobilized into peripheral blood in lymphoma patients.
Enomoto M; Nagayama H; Sato K; Xu Y; Asano S; Takahashi TA
Cytotherapy; 2000; 2(2):95-104. PubMed ID: 12042046
[TBL] [Abstract][Full Text] [Related]
14. Preclinical Assessment of CD171-Directed CAR T-cell Adoptive Therapy for Childhood Neuroblastoma: CE7 Epitope Target Safety and Product Manufacturing Feasibility.
Künkele A; Taraseviciute A; Finn LS; Johnson AJ; Berger C; Finney O; Chang CA; Rolczynski LS; Brown C; Mgebroff S; Berger M; Park JR; Jensen MC
Clin Cancer Res; 2017 Jan; 23(2):466-477. PubMed ID: 27390347
[TBL] [Abstract][Full Text] [Related]
15. Combined G-CSF and Plerixafor enhance hematopoietic recovery of CD34
Arcangeli ML; Brault P; Bourhis JH; Kuhnowskie F; Henry E; Barroca V; Koscielny S; Pflumio F; Amsellem S
Exp Hematol; 2020 Jun; 86():15-20.e2. PubMed ID: 32450206
[TBL] [Abstract][Full Text] [Related]
16. CD30-Redirected Chimeric Antigen Receptor T Cells Target CD30
Hong LK; Chen Y; Smith CC; Montgomery SA; Vincent BG; Dotti G; Savoldo B
Cancer Immunol Res; 2018 Oct; 6(10):1274-1287. PubMed ID: 30087115
[TBL] [Abstract][Full Text] [Related]
17. Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy.
Vedvyas Y; McCloskey JE; Yang Y; Min IM; Fahey TJ; Zarnegar R; Hsu YS; Hsu JM; Van Besien K; Gaudet I; Law P; Kim NJ; Hofe EV; Jin MM
Sci Rep; 2019 Jul; 9(1):10634. PubMed ID: 31337787
[TBL] [Abstract][Full Text] [Related]
18. Modification of NK cell subset repartition and functions in granulocyte colony-stimulating factor-mobilized leukapheresis after expansion with IL-15.
Xiong Y; Mouginot M; Reppel L; Qian C; Stoltz JF; Bensoussan D; Decot V
Immunol Res; 2017 Dec; 65(6):1130-1138. PubMed ID: 29019081
[TBL] [Abstract][Full Text] [Related]
19. Peripheral blood stem cells differ from bone marrow stem cells in cell cycle status, repopulating potential, and sensitivity toward hyperthermic purging in mice mobilized with cyclophosphamide and granulocyte colony-stimulating factor.
Wierenga PK; Setroikromo R; Kamps G; Kampinga HH; Vellenga E
J Hematother Stem Cell Res; 2002 Jun; 11(3):523-32. PubMed ID: 12183837
[TBL] [Abstract][Full Text] [Related]
20. A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing.
Prapa M; Caldrer S; Spano C; Bestagno M; Golinelli G; Grisendi G; Petrachi T; Conte P; Horwitz EM; Campana D; Paolucci P; Dominici M
Oncotarget; 2015 Sep; 6(28):24884-94. PubMed ID: 26298772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
